Trial Watch: Adoptive TCR-Engineered T-Cell Immunotherapy for Acute Myeloid Leukemia

by Diana Campillo-Davo, Sébastien Anguille, Eva Lion
Published 2021-09-01

Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion

by Heleen H. Van Acker, Sébastien Anguille, Sébastien Anguille, Hans De Reu, Zwi N. Berneman, Zwi N. Berneman, Zwi N. Berneman, Evelien L. Smits, Evelien L. Smits, Evelien L. Smits, Viggo F. Van Tendeloo
Published 2018-04-01

Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen

by Marijke Timmers, Gils Roex, Yuedi Wang, Diana Campillo-Davo, Viggo F. I. Van Tendeloo, Yiwei Chu, Zwi N. Berneman, Zwi N. Berneman, Feifei Luo, Feifei Luo, Heleen H. Van Acker, Sébastien Anguille, Sébastien Anguille
Published 2019-07-01

Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC.

by Eva Lion, Sébastien Anguille, Zwi N Berneman, Evelien L J M Smits, Viggo F I Van Tendeloo
Published 2011-01-01

Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data

by Gils Roex, Tom Feys, Yves Beguin, Tessa Kerre, Xavier Poiré, Philippe Lewalle, Peter Vandenberghe, Dominique Bron, Sébastien Anguille
Published 2020-02-01

Meeting the Challenges in Cancer Care Management During the SARS-Cov-2 Pandemic: A Retrospective Analysis

by Marika Rasschaert, Pieterjan Vanclooster, Laura Depauw, Tim Mertens, Ella Roelant, Elke Coenen, Sebastien Anguille, Annelies Janssens, Peter Van Dam, Marc Peeters
Published 2021-10-01

Absence of BCL-2 Expression Identifies a Subgroup of AML with Distinct Phenotypic, Molecular, and Clinical Characteristics

by Inke De haes, Amélie Dendooven, Marie Le Mercier, Pauline Puylaert, Katrien Vermeulen, Mark Kockx, Kathleen Deiteren, Marie-Berthe Maes, Zwi Berneman, Sébastien Anguille
Published 2020-09-01

Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma

by Gils Roex, Marijke Timmers, Kristien Wouters, Diana Campillo-Davo, Donovan Flumens, Wilfried Schroyens, Yiwei Chu, Zwi N. Berneman, Eva Lion, Feifei Luo, Sébastien Anguille
Published 2020-12-01

Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer

by Sévérine de Bruijn, Sébastien Anguille, Joris Verlooy, Evelien L. Smits, Viggo F. van Tendeloo, Maxime de Laere, Koenraad Norga, Zwi N. Berneman, Eva Lion
Published 2019-09-01

The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy

by Diana Campillo-Davo, Maxime De Laere, Gils Roex, Maarten Versteven, Donovan Flumens, Zwi N. Berneman, Viggo F. I. Van Tendeloo, Sébastien Anguille, Eva Lion
Published 2021-03-01

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells

by Heleen H. Van Acker, Sébastien Anguille, Yannick Willemen, Johan M. Van den Bergh, Zwi N. Berneman, Eva Lion, Evelien L. Smits, Viggo F. Van Tendeloo
Published 2016-09-01

Correction: Interleukin-15-Induced CD56+ Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential

by Sébastien Anguille, Eva Lion, Jurjen Tel, I. Jolanda M de Vries, Karen Couderé, Phillip D. Fromm, Viggo F. Van Tendeloo, Evelien L. Smits, Zwi N. Berneman
Published 2014-01-01

Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner.

by Sébastien Anguille, Heleen H Van Acker, Johan Van den Bergh, Yannick Willemen, Herman Goossens, Viggo F Van Tendeloo, Evelien L Smits, Zwi N Berneman, Eva Lion
Published 2015-01-01

Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.

by Sébastien Anguille, Eva Lion, Jurjen Tel, I Jolanda M de Vries, Karen Couderé, Phillip D Fromm, Viggo F Van Tendeloo, Evelien L Smits, Zwi N Berneman
Published 2012-01-01

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia

by Heleen H. Van Acker, Maarten Versteven, Felix S. Lichtenegger, Gils Roex, Diana Campillo-Davo, Eva Lion, Marion Subklewe, Viggo F. Van Tendeloo, Zwi N. Berneman, Sébastien Anguille
Published 2019-04-01

Rapid Assessment of Functional Avidity of Tumor-Specific T Cell Receptors Using an Antigen-Presenting Tumor Cell Line Electroporated with Full-Length Tumor Antigen mRNA

by Diana Campillo-Davo, Maarten Versteven, Gils Roex, Hans De Reu, Sanne van der Heijden, Sébastien Anguille, Zwi N. Berneman, Viggo F. I. Van Tendeloo, Eva Lion
Published 2020-01-01

Correction: Interleukin-15-Induced CD56 Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential.

by Sébastien Anguille, Eva Lion, Jurjen Tel, I. Jolanda M de Vries, Karen Couderé, Phillip D. Fromm, Viggo F. Van Tendeloo, Evelien L. Smits, Zwi N. Berneman
Published 2014-01-01

CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15

by Heleen H. Van Acker, Zoë P. Van Acker, Maarten Versteven, Peter Ponsaerts, Daniela Pende, Zwi N. Berneman, Sébastien Anguille, Viggo F. Van Tendeloo, Evelien L. Smits
Published 2019-07-01

Design of an Optimized Wilms’ Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo

by Daphné Benteyn, Sébastien Anguille, Sandra Van Lint, Carlo Heirman, An MT Van Nuffel, Jurgen Corthals, Sebastian Ochsenreither, Wim Waelput, Katrien Van Beneden, Karine Breckpot, Viggo Van Tendeloo, Kris Thielemans, Aude Bonehill
Published 2013-01-01